Glaxosmithkline Pharmaceuticals

Glaxosmithkline Pharmaceuticals

GLAXO

 ₹ 2,388.20
- ₹ 36.19
1.49%
Healthcare
 ₹ 0.00
(%)1D
Updated: 18 Nov 2024, 02:06:59 pm IST
Stock Score
Open Price
 ₹ 2,436.48
Prev. Close
 ₹ 2,424.39
 ₹ 2,366.94
Day Low
 ₹ 2,443.62
Day High

 ₹ 1,611.10
52 Week Low
 ₹ 3,252.01
52 Week High

Quick Bite

Price To Earnings Ratio

68.57

Sector PE

65.26

PB Ratio

22.64

Sector PB

8.76

EPS

34.83

Dividend Yield

1.65

Today's Volume

25.290 K

5 Day Avg. Volume

58.335 K

PEG Ratio

-20.23

Market Cap.

₹ 41,630.00 Cr.

Sector
Sector
Market Cap
Market Cap

Returns Comparison

TimeGLAXOVSIndustry
1 Day-1.05%-0.63%
1 Week-3.9%-3.75%
1 Month-7.41%-6.27%
6 Months-6.34%13.39%
1 Year62.07%45.97%

StockGro Trade Views 👍

StockGro Trade Views 👍
Login to view TradeViews

Technical Trend

Bearish
academy home
Bearish
Neutral
Bullish

Pivot Levels

R3 ₹ 2,516.09
R2 ₹ 2,479.85
R1 ₹ 2,439.41
RESISTANCE
 ₹ 2,403.17
SUPPORT
S1 ₹ 2,362.73
S2 ₹ 2,326.49
S3 ₹ 2,286.05

Updated: 22 Jul 2024,09:18:33 am IST

Moving Averages

Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
6
Buy
0
Period (Days)SMAIndication
102498.16Bearish
202548.6Bearish
302583.51Bearish
502643.99Bearish
1002765.08Bearish
2002596.22Bearish

Updated: 18 Nov 2024, 01:59:58 pm IST

Forecasts 🧭

Forecasts 🧭
Login to view Forecasts

Analyst Rankings 👍

Analyst Rankings 👍
Login to view Analyst Ranking

Shareholding Updates

PromotersPublicDIIFIIOthers
75%
Promoters
Sep 2024
Promoters  75%
FII  4.36%
DII  7.33%
Public  13.3%
Others  0.01%

Mutual Fund Ownership 👍

Mutual Fund Ownership 👍
Login to view Mutual Fund Ownership

Stock Score 🌟

Stock Score 🌟
Login to view Stock Score

Cash Flow

AnnualFY 2024FY 2023FY 2022
Operating Activities582.02484.23810.75
Investing Activities8.71807.85-405.51
Financing Activities-561.50-1543.32-524.24
Net Cash Flow29.23-251.25-119.00

All Figures in ₹ Cr., unless mentioned otherwise

Ratios

Return on Equity (%)

Income Statement

All Figures in ₹ Cr., unless mentioned otherwise

Balance Sheet

All Figures in ₹ Cr., unless mentioned otherwise

Peer Comparison

Name1D (%)1W (%)1M (%)6M (%)1Y (%)
Glaxosmithkline Pharmaceuticals-1.05-3.9-7.41-6.3462.07
Alembic-1.23-4.7-4.91-6.33-6.33
Aurobindo Pharma-0.78-6.31-15.06-3.4320.87
Fortis Healthcare-0.453.076.2631.1973.67
Ajanta Pharmaceuticals1.682.57-9.8411.2148.34
Returns as on 18 Nov, 2024

About Glaxosmithkline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company has three product areas: vaccines, specialty and general medicine. Its general medicines business has a portfolio of medicines in anti-infectives, pain, vitamins medicine, nutritional, hormones, dermatologicals, respiratory and vaccines for adults and children. The Company's general medicine brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, Tenovate, T-bact and Physiogel. The Company's vaccine brands include Shingrix Herpes Zoster Vaccine, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients. The Subsidiary of the Company is Biddle Sawyer Limited.

Glaxosmithkline Pharmaceuticals Share Price

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The company's field of activity is the production, distribution and trade of medicines. It produces drugs used in the pharmaceutical industry, such as antibiotics, endocrine products, essential vitamins; opium derivatives; sulfa drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and plant alkaloids and chemically pure sugar. It offers a variety of prescription drugs, vaccines and consumer health products. Its drug portfolio includes Adartrel, Bactroban, Combodart and Duodart. Its vaccine portfolio includes Ambirix, Cervarix, Fendrix and Havrix. The company's products include betamethasone, clavulanate potassium with amoxicillin, and pneumococcal polysaccharide and conjugate vaccine. Its oral care products include Sensodyne, parodontax and Polident. Its manufacturing unit is located in Nashik.

Glaxosmithkline Pharmaceuticals FAQs

How to Buy Glaxosmithkline Pharmaceuticals Share?

up
To purchase Glaxosmithkline Pharmaceuticals shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Glaxosmithkline Pharmaceuticals (ticker symbol: GLAXO) on the trading platform provided by your broker and purchase the shares.

What's Glaxosmithkline Pharmaceuticals share price today?

up
The stock price of Glaxosmithkline Pharmaceuticals as of 18 Nov 2024 is ₹2,388.20

What is the Market Cap of Glaxosmithkline Pharmaceuticals?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 18 Nov 2024, Glaxosmithkline Pharmaceuticals (ticker symbol: GLAXO) has a market capitalisation of approximately ₹4,16,30,00,00,000.00

What is the PE and PB ratio of Glaxosmithkline Pharmaceuticals?

up
Glaxosmithkline Pharmaceuticals Ltd's price-to-book ratio as of 18 Nov 2024 is 22.64, reflecting the market's valuation compared to its asset value. As of 18 Nov 2024, the trailing twelve months P/E (price-to-earnings) ratio is 68.57, indicating the market values the company at around ₹68.57 for every ₹1 of earnings

What is the 52 Week High and Low of Glaxosmithkline Pharmaceuticals Share?

up
Glaxosmithkline Pharmaceuticals Ltd (GLAXO) hit its 52-week high at ₹3,252.01, and its 52-week low at ₹1,611.10.
Want to learn and earn in Stocks?
Login/Register
View All Global Indices
View More
Start Learning